AU502937B2 - Hydrocortisone composition - Google Patents

Hydrocortisone composition

Info

Publication number
AU502937B2
AU502937B2 AU11232/76A AU1123276A AU502937B2 AU 502937 B2 AU502937 B2 AU 502937B2 AU 11232/76 A AU11232/76 A AU 11232/76A AU 1123276 A AU1123276 A AU 1123276A AU 502937 B2 AU502937 B2 AU 502937B2
Authority
AU
Australia
Prior art keywords
weight
composition
hydrocortisone
propylene glycol
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU11232/76A
Other languages
English (en)
Other versions
AU1123276A (en
Inventor
H. Whitefield M Yarrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diomed Developments Ltd
Original Assignee
DERMAL LAB Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DERMAL LAB Ltd filed Critical DERMAL LAB Ltd
Publication of AU1123276A publication Critical patent/AU1123276A/en
Application granted granted Critical
Publication of AU502937B2 publication Critical patent/AU502937B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU11232/76A 1975-02-19 1976-02-19 Hydrocortisone composition Expired AU502937B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB7030/75 1975-02-19
GB7030/75A GB1543907A (en) 1975-02-19 1975-02-19 Steroid compositions

Publications (2)

Publication Number Publication Date
AU1123276A AU1123276A (en) 1977-08-25
AU502937B2 true AU502937B2 (en) 1979-08-16

Family

ID=9825303

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11232/76A Expired AU502937B2 (en) 1975-02-19 1976-02-19 Hydrocortisone composition

Country Status (7)

Country Link
JP (1) JPS609486B2 (cg-RX-API-DMAC7.html)
AU (1) AU502937B2 (cg-RX-API-DMAC7.html)
DE (1) DE2606516A1 (cg-RX-API-DMAC7.html)
FR (1) FR2341317A1 (cg-RX-API-DMAC7.html)
GB (1) GB1543907A (cg-RX-API-DMAC7.html)
IE (1) IE43270B1 (cg-RX-API-DMAC7.html)
ZA (1) ZA76980B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
AT389447B (de) * 1983-01-27 1989-12-11 Taisho Pharmaceutical Co Ltd Verfahren zur herstellung einer topischen steroidsalbe
JPS59137408A (ja) * 1983-01-27 1984-08-07 Taisho Pharmaceut Co Ltd 軟膏
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
AU4472396A (en) * 1994-12-30 1996-07-24 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions
GB2302808A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Propylene glycol with low potency corticosteroids for topical treatment of the scalp
WO2024252238A1 (en) * 2023-06-06 2024-12-12 HASSEN, Mohammed, Ameen Treatment of psoriasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA725898B (en) * 1972-05-30 1973-05-30 Sackler R Iodophor steroid pharmaceutical compositions
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation

Also Published As

Publication number Publication date
FR2341317B1 (cg-RX-API-DMAC7.html) 1979-06-08
GB1543907A (en) 1979-04-11
ZA76980B (en) 1977-01-26
DE2606516A1 (de) 1976-09-02
AU1123276A (en) 1977-08-25
JPS609486B2 (ja) 1985-03-11
DE2606516C2 (cg-RX-API-DMAC7.html) 1987-09-17
IE43270L (en) 1976-08-19
IE43270B1 (en) 1981-01-28
FR2341317A1 (fr) 1977-09-16
JPS51106713A (cg-RX-API-DMAC7.html) 1976-09-21

Similar Documents

Publication Publication Date Title
AU497066B2 (en) Photocoplymerizable composition
AU504748B2 (en) Corticosteroid composition
AU496790B2 (en) Pourer-stopper
AU1108376A (en) Polyhemoglobin
AU1006976A (en) Inhilator
AU1373876A (en) Bottlecap
AU497446B2 (en) Composition
AU1829576A (en) Hydropyrimidines
AU1667476A (en) Chroman-4-ones
AU501016B2 (en) Propargyl-2 phenylamino-2-impazolines
AU1128976A (en) Magneto-alternator
AU511364B2 (en) Absorption-refrigerant composition
AU1722876A (en) Antimacassar
AU1123276A (en) Hydrocortisone composition
CA1032387A (en) Bookcovers
AU498623B2 (en) Matchhead compositions
AU505910B2 (en) Neamatocidal composition
AU507072B2 (en) Reducing zeearalenone
AU500125B2 (en) Anti-acne composition
AU498384B2 (en) Anti-timor composition
AU505624B2 (en) B-homo steroids
AU505846B2 (en) Fluoro-steroids
AU496964B2 (en) Alpha-pyrones
AU500420B2 (en) 6-aminomethylated 3-oxygenated chloest-5-enes
AU507984B2 (en) Structural section